Cancer Clinical Trial
Official title:
Implementation and Evaluation of Dignity Therapy in Denmark
The purpose of the study is to investigate whether Danish patients with incurable cancer have a need of, interest in and benefit from Dignity Therapy.
Research in palliative care has primarily focused on physical and psychological symptoms.
Research in other psychosocial and existential problems has been sparse. Loss of dignity as
a consequence of serious illness may be an important cause of suffering. The research team
of the Canadian psychiatrist and professor, Harvey Chochinov has investigated the concept of
dignity and developed the psychosocial intervention 'Dignity Therapy' (DT). The preliminary
research results were promising.
Research questions: Do Danish cancer patients have a need of, interest in, and benefit from
DT? Methods: DT consists of an interview revolving around the patient's life, values, and
accomplishments and is also an opportunity to leave messages and words of hope and
compassion for friends and family. The interview is audio taped, transcribed, and edited
together with the patient, and made into a tangible document, which the patient can give to
his/her relatives. The project consists of three parts: (1) a cross-sectional investigation
of the prevalence of loss of dignity and related symptoms/problems among at least 200
incurable cancer patients. (2) A feasibility study, testing the intervention in terms of
relevance and the need of any modifications in relation to Danish patients. (3) An
evaluation study testing the effect of and satisfaction with DT.
At least 80 patients are planned for the feasibility and evaluation studies. Questionnaires
are used for detection of loss of dignity and as measures of effect. These will be
administered before the intervention and, along with a semi-structured evaluation
questionnaire, right after the intervention, when the document is received and again
approximately two weeks later.
The duration of the intervention (DT) varies markedly between patients. In some cases the
process (interview, transcription, editing of document, and the final meeting where the
document is given back to the patient) is completed urgently in a few days, whereas in other
cases, the patient prefers a slower pace, and may want to sub-divide the interview into two
or more parts. Also, when presented with the document, some patients want to have something
changed or they want add material. This variation is seen as intentional, as it illustrates
that the process is tailored to the patient's wishes.
As stated, the effect of the DT intervention is evaluated at completion of the intervention,
i.e. when the final document is given back to the patient, and about two weeks later. Due to
process described above, the time from the first measurement (before intervention) to the
second measurement (which takes places at completion of the intervention) therefore varies
considerably (median 36 days after baseline, range 7-121 days).
Perspective: If Danish patients have a need of, an interest in and benefit from DT, it can
be offered to Danish patients admitted to palliative care.
;
Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Supportive Care
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT05346796 -
Survivorship Plan HEalth REcord (SPHERE) Implementation Trial
|
N/A | |
| Recruiting |
NCT05094804 -
A Study of OR2805, a Monoclonal Antibody Targeting CD163, Alone and in Combination With Anticancer Agents
|
Phase 1/Phase 2 | |
| Completed |
NCT04867850 -
Effect of Behavioral Nudges on Serious Illness Conversation Documentation
|
N/A | |
| Enrolling by invitation |
NCT04086251 -
Remote Electronic Patient Monitoring in Oncology Patients
|
N/A | |
| Completed |
NCT01285037 -
A Study of LY2801653 in Advanced Cancer
|
Phase 1 | |
| Completed |
NCT00680992 -
Study of Denosumab in Subjects With Giant Cell Tumor of Bone
|
Phase 2 | |
| Completed |
NCT00062842 -
Study of Irinotecan on a Weekly Schedule in Children
|
Phase 1 | |
| Active, not recruiting |
NCT04548063 -
Consent Forms in Cancer Research: Examining the Effect of Length on Readability
|
N/A | |
| Completed |
NCT04337203 -
Shared Healthcare Actions and Reflections Electronic Systems in Survivorship
|
N/A | |
| Recruiting |
NCT04349293 -
Ex-vivo Evaluation of the Reactivity of the Immune Infiltrate of Cancers to Treatments With Monoclonal Antibodies Targeting the Immunomodulatory Pathways
|
N/A | |
| Terminated |
NCT02866851 -
Feasibility Study of Monitoring by Web-application on Cytopenia Related to Chemotherapy
|
N/A | |
| Active, not recruiting |
NCT05304988 -
Development and Validation of the EFT for Adolescents With Cancer
|
||
| Completed |
NCT04448041 -
CRANE Feasibility Study: Nutritional Intervention for Patients Undergoing Cancer Surgery in Low- and Middle-Income Countries
|
||
| Completed |
NCT00340522 -
Childhood Cancer and Plexiform Neurofibroma Tissue Microarray for Molecular Target Screening and Clinical Drug Development
|
||
| Recruiting |
NCT04843891 -
Evaluation of PET Probe [64]Cu-Macrin in Cardiovascular Disease, Cancer and Sarcoidosis.
|
Phase 1 | |
| Active, not recruiting |
NCT03844048 -
An Extension Study of Venetoclax for Subjects Who Have Completed a Prior Venetoclax Clinical Trial
|
Phase 3 | |
| Completed |
NCT03167372 -
Pilot Comparison of N-of-1 Trials of Light Therapy
|
N/A | |
| Completed |
NCT03109041 -
Initial Feasibility Study to Treat Resectable Pancreatic Cancer With a Planar LDR Source
|
Phase 1 | |
| Terminated |
NCT01441115 -
ECI301 and Radiation for Advanced or Metastatic Cancer
|
Phase 1 | |
| Recruiting |
NCT06206785 -
Resting Energy Expenditure in Palliative Cancer Patients
|